![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Abbott’s Premie Heart Opening Treatment
FDA Approves Abbott’s Premie Heart Opening Treatment
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
The FDA approved Abbott’s Amplatzer Piccolo occlude, a device that can be implanted in babies weighing as little as two pounds to treat patent ductus arteriosus.
The minimally-invasive device, which is smaller than a pea, is able to treat the life-threatening opening between two blood vessels leading from the heart that can occur, most often in babies born prematurely.
The self-expanding, wire mesh device is inserted in the baby via a small insertion in the leg and directed through vessels to the heart, where it is placed to seal the opening.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct